- sales@expolake.com
- +1-469-567-9589
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
The BIO-Europe 2026 event will bring together companies from the fields of biotechnology, biopharmaceuticals, pharma, clinical research, investment, and life sciences, the organisations being involved in partnering, drug development, licensing and healthcare innovation.
They develop new therapies, biological products, drug candidates, and biotechnology platforms to meet various medical needs.
The companies in question are those involved in the pharmaceutical field and focused on drug development, carrying out preclinical development, commercialization, anestablishingof healthcare partnerships.
Firms that offer to biopharma organizations contract research, clinical development, manufacturing, formulation, testing, and various other specialized services.
They provide assistance with licensing, partnering, commercialization, alliance management, and business development in the life sciences industry.
Firms that provide venture capital, private equity groups, investment companies, and various financial organizations which support biotechnology and pharmaceutical businesses.
The companies offer a range of specialised services to the biopharma industry, including laboratory technologies, diagnostics, clinical solutions, data platforms, research tools and others.
Chief executive officers, founders, senior executives, and business leaders from biotechnology and biopharmaceutical companies involved in organizational growth, partnerships, and strategic development.
Pharmaceutical executives, drug development specialists, commercial leaders, and professionals involved in pharmaceutical research and business operations.
Business development managers, licensing specialists, alliance professionals, and partnering teams pursuing collaboration and licensing opportunities.
Scientists, researchers, research and development leaders, and drug development professionals involved in therapeutic development and life sciences research.
Clinical development specialists, clinical research professionals, regulatory teams, and subject matter experts advancing pharmaceutical and biotechnology programs.
Venture capital investors, private equity professionals, investment managers, analysts, and financial specialists focused on biotechnology and healthcare opportunities.
The database comprises biotech executives, pharmaceutical leaders, business development professionals, investors, licensing specialists, researchers, and other key decision-makers in the life sciences sector.
All contact information is professionally verified to identify relevant prospects across biotechnology, biopharma, pharmaceuticals, clinical research, and life sciences.
The database supports email marketing, LinkedIn outreach, appointment setting, telemarketing, account-based marketing, and post-event follow-up.
Each record contains contact details, job titles, organization type, seniority, location, company information, therapeutic area, biotechnology specialization, and partnering focus.
Contacts can be segmented by therapeutic area, biotechnology specialization, job role, seniority, company size, geography, business development focus, licensing interests, and attendee or exhibitor status.
The BIO-Europe 2026 database is delivered in Excel or CSV format for easy integration with CRM, sales, and marketing platforms.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
Gain access to biotechnology executives, pharmaceutical leaders, business development specialists, investors, licensing professionals, researchers, and key decision-makers in the life sciences sector.
Engage targeted prospects before the conference to present your solutions, schedule meetings, and build relationships with potential partners.
Connect with professionals assessing biotechnology solutions, pharmaceutical services, contract research and manufacturing (CRO/CDMO) capabilities, clinical research technologies, and life sciences products.
Engage companies and professionals in biotechnology, pharmaceuticals, drug development, clinical research, investment, licensing, and healthcare technology.
Follow up with pertinent attendees and exhibitors after BIO-Europe 2026 to strengthen relationships, advance discussions, and cultivate future business opportunities.
Enhance yEnhance your exhibiting, partnering, sponsorship, sales, and marketing initiatives using relevant contact data before, during, and after the event.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
The list can include biotechnology executives, researchers, scientists, and other individuals who are working in the field of biotechnology and life sciences.
You could obtain segmented contacts of pharmaceutical executives, drug development specialists, and other individuals working in the pharma industry.
The database can include business development managers, partnering specialists, licensing professionals, and alliance teams.
The database could include venture capital, private equity, investment, and financial professionals who specialise in biotechnology and healthcare.
The contacts can include people who are engaged in clinical development, clinical research, regulatory positions, and other areas within the life sciences.
